PAI1 stimulates assembly of the fibronectin matrix in osteosarcoma cells through crosstalk between the αvβ5 and α5β1 integrins

Journal of Cell Science

Volumn 121, Issue 10, 2008, Pages 1661-1670

  Vial, Daniel ^a   McKeown Longo, Paula J ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Actin; Extracellular matrix; Fibronectin; Integrin; PAI1

Indexed keywords

ALPHAVBETA5 INTEGRIN; FIBRONECTIN; INTEGRIN RECEPTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; TENSIN; UROKINASE; UROKINASE RECEPTOR; VERY LATE ACTIVATION ANTIGEN 5; VITRONECTIN;

ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FOCAL ADHESION; HUMAN; HUMAN CELL; MUTANT; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; STRESS FIBER;

ACTINS; ADHESIONS; CELL LINE, TUMOR; FIBRONECTINS; HUMANS; INTEGRIN ALPHA5BETA1; OSTEOSARCOMA; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECEPTOR CROSS-TALK; RECEPTORS, VITRONECTIN; VITRONECTIN;

EID: 46249125497     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.020149     Document Type: Article

References (34)

1. Aguirre-Ghiso, J. A., Liu, D., Mignatti, A., Kovalski, K. and Ossowski, L. (2001). Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo. Mol. Biol. Cell 12, 863-879.
2. Arnaout, M. A., Goodman, S. L. and Xiong, J. (2007). Structure and mechanics of integrin-based cell adhesion. Curr. Opin. Cell Biol. 19, 495-507.
3. Brenner, K. A., Corbett, S. A. and Schwarzbauer, J. (2000). Regulation of fibronectin matrix assembly by activated Ras in transformed cells. Oncogene 19, 3156-3163.
4. Chambers, S. K., Irvins, C. M. and Carcamgiu, M. L. (1998). Plasminogen activator inhibitor-1 is an independent poor prognostic factor for survival in advanced stage epithelial ovarian cancer patients. Int. J. Cancer 79, 449-454.
5. Czekay, R.-P., Aertgeerts, K., Curriden, S. A. and Loskutoff, D. (2003). Plasminogen activator inhibitor- 1 detaches cells from extracellular matrices by inactivating integrins. J. Cell Biol. 160, 781-791.
6. Degryse, B., Resnati, M., Czekay, R.-P., Loskutoff, D. J. and Blasi, F. (2005). Domain 2 of the urokinase receptor contains an integrin-interacting epitope with intrinsic signaling activity: generation of a new integrin inhibitor. J. Biol. Chem. 280, 24792-24803.
7. Deng, G., Curriden, S. A., Wang, S., Rosenberg, S. and Loskutoff, D. J. (1996). Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? J. Cell Biol. 134, 1563-1571.
8. Deng, G., Curriden, S. A., Hu, G., Czekay, R. P. and Loskutoff, D. J. (2001). Plasminogen activator inhibitor-1 regulates cell adhesion by binding to the somatomedin B domain of vitronectin. J. Cell. Physiol. 189, 23-33.
9. Edlund, M., Lotano, M. A. and Otey, C. A. (2001), Dynamics of a-actinin in focal adhesion and stress fibers visualized with a-actinin-green fluorescent protein. Cell Motil. Cytoskeleton 48, 190-200.
10. Foekens, J. A., Peters, H. A., Look, M. P., Portengen, H., Schmitt, M., Kramer, M. D., Brunner, N., Janicke, F., Meijer-van Gelder, M. E., Henzen-Logmans, S. C. et al. (2000). The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients. Cancer Res. 60, 636-643.
11. Franco, P., Vocca, I., Carriero, M. V., Alfano, D., Cito, L., Longanesi-Cattani, I., Grieco, P., Ossowski, L. and Stappelli, M. P. (2006). Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and αvβ5 integrin. J. Cell Sci. 119, 3424-3434.
12. Giannone, G., Jiang, G., Sutton, D. H., Critchley, D. R. and Sheetz, M. P. (2003). Talin1 is critical for force-dependent reinforcement of initial integrin-cytoskeletan bonds but not tyrosine kinase activation. J. Cell Biol. 163, 409-419.
13. Harris, S., Eager, R. J., Riggs, B. L. and Spelsberg, T. C. (1995). Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J. Bone Miner Res. 10, 178-186.
14. Higgins, P. J., Ryan, M. P. and Chaudhari, P. (1989). Cytochalasin D-mediated hyperinduction of the substrate-associated 52-kilodalton protein p52 in rat kidney fibroblasts. J. Cell. Physiol. 139, 407-417.
15. Hocking, D. C., Sottile, J., Reho, T., Fassler, R. and McKeown-Longo, P. J. (1999). Inhibition of fibronectin matrix assembly by the heparin-binding domain of vitronectin. J. Biol. Chem. 274, 27257-27264.
16. Isogai, C., Laug, W. E., Shimada, H., Declerck, P. J., Stins, M. F., Darden, D. L., Erdreich-Epstein, A. and DeClerck, Y. A. (2001). Plasminogen activator inhibitor-1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin. Cancer Res. 61, 5587-5594.
17. Lawrence, D. A., Berkenpas, M. B., Palaniappan, S. and Ginsburg, D. (1994). Localization of vitronectin binding domain in plasminogen activator inhibitor-1. J. Biol. Chem. 269, 15223-15228.
18. Monaghan, E., Gueorguiev, V., Wilkins-Port, C. and McKeown-Longo, P. J. (2004). The receptor for urokinase-type plasminogen activator regulates fibronectin matrix assembly in human skin fibroblasts. J. Biol. Chem. 279, 1400-1407.
19. Monaghan-Benson, F. and McKeown-Longo, P. J. (2006). uPAR regulates a novel pathway of fibronectin matrix assembly requiring Src dependent transactivation of EGFR. J. Biol. Chem. 281, 9450-9459.
20. Mould, A. P., Askari, J. A., Barton, S., Kline, A. D., McEwan, P. A., Craig, S. E. and Humphries, M. J. (2002). Integrin activation involves a conformational change in the α1 helix of the β subunit A-domain. J. Biol. Chem. 277, 19800-19805.
21. Okumura, Y., Kamikubo, Y., Curriden, S. A., Wang, J., Kiwada, T., Futaki, S., Kitagawa, K. and Loskutoff, D. J. (2002). Kinetic analysis of the interaction between vitronectin and the urokinase receptor. J. Biol. Chem. 277, 9395-9404.
22. Salasznyk, R. M., Zappala, M., Zheng, M., Yu, L., Wilkins-Port, C. and McKeown-Longo, P. J. (2007). The uPA receptor and the somatomedin B region of vitronectin direct the localization of uPA to focal adhesions in microvessel endothelial cells. Matrix Biol. 26, 359-370.
23. Schmitt, M., Janicke, F., Moniwa, N., Chucholowski, N., Pache, L. and Graeff, H. (1992). Tumor-associated urokinase type plasminogen activator: biological and clinical significance. Biol. Chem. Hoppe Seyler 373, 611-622.
24. Seiffert, D. and Loskutoff, D. J. (1991). Kinetic analysis of the interaction between type 1 plasminogen activator inhibitor and vitronectin and evidence that the bovine inhibitor binds to a thrombin-derived amino-terminal fragment of bovine vitronectin. Biochim. Biophys. Acta 1078, 23-30.
25. 3 binding to vitronectin. Nature 383, 441-443.
26. Stefansson, S., Su, E. J., Ishigami, S., Cale, J. M., Gao, Y., Gorlatova, N. and Lawrence, D. A. (2007). The contributions of integrin affinity and integrin-cytoskeletal engagement in endothelial and smooth muscle cell adhesion to vitronectin. J. Biol. Chem. 282, 15679-15689.
27. Takahashi, T., Suzuki, K., Ihara, H., Mogami, H., Kazui, T. and Urano, T. (2005). Plasminogen activator inhibitor type 1 promotes fibrosarcoma cell migration by modifying cellular attachment to vitronectin via αvβ5 integrin. Semin. Thromb. Hemost. 31, 356-363.
28. Vial, D., Monaghan-Benson, E. and McKeown-Longo, P. J. (2006). Coordinate regulation of fibronectin matrix assembly by the plasminogen activator system and vitronectin in human osteosarcoma cells. Cancer Cell Int. 6, 8.
29. Wei, Y., Lukashev, M., Simon, D. I., Bodary, S. C., Rosenberg, S., Doyle, M. V. and Chapman, H. A. (1996). Regulation of integrin function by the urokinase receptor. Science 273, 1551-1555.
30. Wierzbicka-Patynowski, I. and Schwarzbauer, J. E. (2003). The ins and outs of fibronectin matrix assembly. J. Cell Sci. 116, 3269-3276.
31. Yatohgo, T., Izumi, M., Kashiwagi, H. and Hayashi, M. (1988). Novel purification of vitronectin from human plasma by heparin affinity chromatography. Cell Struct. Funct. 13, 281-292.
32. Zhang, Q., Peyruchaud, O., French, K. J., Magnusson, M. K. and Mosher, D. F. (1999). Sphingosine 1-phosphate stimulates fibronectin matrix assembly through a Rhodependent signal pathway. Blood 93, 2984-2990.
33. Zheng, M. and McKeown-Longo, P. J. (2002). Regulation of HEF1 expression and phosphorylation by TGF-β1 and cell adhesion. J. Biol. Chem. 277, 39599-39608.
34. Zheng, M., Ambesi, A., Yu, L. and McKeown-Longo, P. J. (2007). Quantification of fibronectin matrix assembly sites using a novel ELISA assay. Matrix Biol. 26, 330-333.